SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a low rate of complications[i]

SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform.

Butterfly Network (NYSE:BFLY) announced today that it received FDA clearance for its next-generation handheld ultrasound system.

Medtronic (NYSE: MDT)+
announced today that it received CE mark approval for its MiniMed 780G system with Simplera Sync.

Medtronic (NYSE: MDT)+
today announced FDA approval of its Percept RC deep brain stimulation system, the latest member of its Percept line of DBS devices.

Zoll this week announced it received FDA clearance and CE mark approval for upgrades to its Thermogard temperature management system